Pestilence via Kill Shots: ba.2 is a Subvariant of Omicron, Which is a Variant of the CCP (Chinese Communist Party) Virus — Covid-19 Treatments That Are Not Effective Against ba.2 Include Paxlovid, a Pill Developed by Pfizer, and Remdesivir, an Antiviral Developed by Gilead Sciences. There is No Cure for Pestilence
You’ve Been Lied To, if You're Complying With a Government, There Objective is Genocide, You're Going Along With Your Own Execution...“When the Nazis Came to Power in 1933, the German Constitution Guaranteed Freedom of Speech and Freedom of the Press.
Through Decrees and Laws, the Nazis Abolished These Civil Rights and Destroyed German Democracy. Starting in 1934, It Was Illegal to Criticize the Nazi Government. Even Telling a Joke About Hitler Was Considered Treachery. People in Nazi Germany Could Not Say or Write Whatever They Wanted.”
The Nazis Wanted Germans to Support the Nazi Dictatorship and Believe in Nazi Ideas. To Accomplish This Goal, They Tried to Control Forms of Communication Through Censorship and Propaganda. This Included Control of Newspapers, Magazines, Books, Art, Theater, Music, Movies, and Radio Just Like Fakebook, Google, YouTube and the Major Platforms ,Censorship for Your Own Good...
HNewsWire-Health care providers in eight states have been told to avoid using a COVID-19 therapy because it may not be effective against an Omicron subvariant that is becoming more common. Pestilence Has No Cure!
Sotrovimab, a monoclonal antibody used to treat COVID-19, is no longer approved for use in Connecticut, Maine, Massachusetts, New Hampshire, New Jersey, New York, Rhode Island, and Vermont, according to the Food and Drug Administration.
Stotrovimab is likewise being advised to be avoided by providers in Puerto Rico and the Virgin Islands.
The FDA said in a statement that the medication, which was granted emergency use authorization in May 2021, "is unlikely to be effective against the BA.2 subvariant."Pestilence via Kill Shots
Pestilence via Kill Shots BA.2 is a sub-type of Omicron, a CCP (Chinese Communist Party) viral variety.
BA.2 was responsible for 12.6 percent of COVID-19 infections in the United States in the week ending March 5, according to genomic monitoring done by the Centers for Disease Control and Prevention. However, the agency predicted a 35 percent spike in the week ending March 19, and the subvariant was said to be widespread in the northeast.
According to estimations, BA.2 is responsible for the bulk of instances in places where sotrovimab administration is currently restricted.
The FDA had said in February that the therapy would be limited.
Several investigations, including one published in Nature Medicine, have shown that sotrovimab is ineffective against BA.2.
The drug's producers, GlaxoSmithKline and Vir Biotechnology, have indicated that tests show the medication still has BA.2-neutralizing effect.
The businesses stated Friday that they were aware of the FDA's decision and that they are planning to deliver a data package to the agency and other regulatory bodies demonstrating that a higher dosage of sotrovimab is effective against BA.2.
According to the FDA, COVID-19 therapies that seem to be effective against BA.2 include Pfizer's paxlovid tablet, Gilead Sciences' remdesivir antiviral, and Eli Lilly's newly approved bebtelovimab monoclonal.
"We will continue to monitor BA.2 throughout the United States and may alter the authorisation to ensure that COVID-19 patients have access to appropriate therapies." "As they pick suitable treatment choices for patients, health care practitioners should also monitor the incidence of BA.2 in their location," the FDA added.
The FDA previously revoked approval for REGEN-COV, a Regeneron monoclonal, and a different Eli Lilly therapy after laboratory testing revealed they weren't effective against Omicron.Pestilence via Kill Shots Has NO Cure
“Trust the science.” This week Dr. Kobi Haviv, the medical director of Israel’s leading center for respiratory care, joined the country’s Channel 13 News to share an extremely concerning update regarding breakthrough cases among the vaccinated.
The Israeli Ministry of Health announced this week that more than 72,000 people tested positive for the CCP (Chinese Communist Party) virus, the largest rise in infections since the start of the pandemic.
Total active cases in the country rose to nearly 400,000 people, of whom 533 are currently hospitalized in critical condition, according to a Jan. 19 statement posted by the country’s health ministry.
Israeli Prime Minister Naftali Bennett warned this month that CCP virus cases are expected to increase rapidly amid the spread of the Omicron variant, as he presented government data that indicates two to four million Israelis are predicted to be infected with COVID-19 during the current outbreak.
“Information presented at a cabinet meeting indicates that in Israel, overall 2–4 million citizens will be infected in the current wave,” Bennett’s statement reads.
Israel, which has one of the highest COVID-19 vaccination rates in the world with already nearly half of its citizens having received three shots, is leading the world in new daily cases per capita, according to Jan. 20 data.
Eran Segal, a biologist at the Weizmann Institute of Science, verified this data, explaining that after comparing the numbers of each country’s seven-day running average, Israel is at the top, The Times of Israel reported.
The country’s health ministry announced last week it started administering second boosters to the most vulnerable group of people and already 500,000 people have received the fourth shot. In total, nearly 73 percent of Israeli’s have received at least one dose while roughly 66 percent are fully vaccinated, according to government data.
Israel was among the first countries to roll out vaccines a year ago and began widely offering third doses last summer in a bid to contain the Delta variant. Authorities have said they hope the fourth shot will blunt a wave of infections driven by Omicron.
An Israeli researcher said on Jan. 17 a second booster dose of Pfizer’s COVID-19 vaccine does induce antibodies, but likely not at a level high enough to protect recipients against infection from Omicron. Much of Israel’s COVID-19 vaccination program uses the Pfizer jab.
“Two weeks after administering the fourth vaccine, we see a good increase in the antibodies, higher than after the third dose, but not high enough against Omicron,” lead researcher Prof. Gili Regev-Yochay told reporters in an online briefing.
Omicron has proven better at evading antibodies induced by COVID-19 vaccines than earlier strains and has infected millions of vaccinated people around the world in recent weeks, sparking a renewed effort to get people boosted.
On Tuesday, Bennett again encouraged Israelis to get jabbed. The leader promoted earlier preliminary results from a Sheba Medical Center study that showed a high level of antibodies a week after workers received the fourth dose, touting “a five-fold increase in the number of antibodies” in the recipient of the vaccine.
The early data indeed indicated that the booster restored some of the lost protection against infection, but that the protection again dropped after just a few weeks. Similar results have come in for the second booster, according to preliminary results from the Sheba study, which have not yet been published.
Zachary Stieber contributed to this report.
HNewsWire- With millions of Americans still struggling to buy COVID tests at pharmacies and on Amazon, President Joe Biden has decided to order the federal government to procure another 500MM COVID tests to meet "future demand", according to media reports leaked to preview a speech that Biden will make later in the day.
Satan Soldier Biden announced during a White House address on Thursday that he ordered the deployment of six military medical teams to six “hard hit” states dealing with a surge in cases of the COVID-19 Omicron variant.
The six military medical teams — consisting of a total of 120 medical professionals — will be sent to hospitals in Michigan, New York, New Jersey, Ohio, Rhode Island and New Mexico, Biden said.
The president, who has been criticized for not focusing enough on testing, is also preparing to dispatch more military personnel to aide struggling US hospitals, which remain overwhelmed.
According to their health officials, the majority of Israelis have been fully vaccinated, including 85% of those who are eligible. Out of the estimated 9.3 million citizens, 5.8 million have received at least one shot and 5.4 million are fully vaccinated.
Despite most of them taking the jab, the country has seen a quick spike in cases that has resulted in more daily positive test results than they had on the same day last year. On Thursday they had 3,843 new cases.
The Israeli Health Ministry used the data to justify tightening restrictions for their authoritarian vaccine passports.
Israel, which has one of the highest COVID-19 vaccination rates in the world with already nearly half of its citizens having received three shots, is leading the world in new daily cases per capita, according to Jan. 20 data.
Eran Segal, a biologist at the Weizmann Institute of Science, verified this data, explaining that after comparing the numbers of each country’s seven-day running average, Israel is at the top, The Times of Israel reported.
The country’s health ministry announced last week it started administering second boosters to the most vulnerable group of people and already 500,000 people have received the fourth shot. In total, nearly 73 percent of Israeli’s have received at least one dose while roughly 66 percent are fully vaccinated, according to government data.
Insurance companies are reporting a jump in death payouts due to a dramatic rise in the number of deaths. The rise in the death rate is being corroborated by death certificate data from the Centers for Disease Control and Prevention (CDC).
The death rate is up by 40 percent from pre-pandemic levels according to Scott Davison, chief executive of OneAmerica, a major insurance company based in Indianapolis. During an online news conference on Dec. 30, 2021, Davison said the change was unprecedented.
“We are seeing, right now, the highest death rates we have seen in the history of this business,” he said.
OneAmerica sells life insurance to employers nationwide, and similar figures are found throughout the industry.
